Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellectis (CLLS) Liabilities and Shareholders Equity (2016 - 2023)

Historic Liabilities and Shareholders Equity for Cellectis (CLLS) over the last 11 years, with Q3 2023 value amounting to $209.7 million.

  • Cellectis' Liabilities and Shareholders Equity fell 2499.46% to $209.7 million in Q3 2023 from the same period last year, while for Dec 2023 it was $688.8 million, marking a year-over-year decrease of 2006.51%. This contributed to the annual value of $261.2 million for FY2022, which is N/A changed from last year.
  • As of Q3 2023, Cellectis' Liabilities and Shareholders Equity stood at $209.7 million, which was down 2499.46% from $227.7 million recorded in Q2 2023.
  • Over the past 5 years, Cellectis' Liabilities and Shareholders Equity peaked at $511.9 million during Q1 2019, and registered a low of $209.7 million during Q3 2023.
  • For the 5-year period, Cellectis' Liabilities and Shareholders Equity averaged around $392.8 million, with its median value being $462.5 million (2019).
  • In the last 5 years, Cellectis' Liabilities and Shareholders Equity soared by 5798.22% in 2019 and then tumbled by 3228.64% in 2022.
  • Cellectis' Liabilities and Shareholders Equity (Quarter) stood at $467.5 million in 2019, then increased by 0.43% to $469.5 million in 2020, then fell by 12.05% to $412.9 million in 2021, then tumbled by 36.73% to $261.2 million in 2022, then dropped by 19.72% to $209.7 million in 2023.
  • Its last three reported values are $209.7 million in Q3 2023, $227.7 million for Q2 2023, and $251.4 million during Q1 2023.